Diabetic nephropathy (DN) is one of the most common complications in patients with diabetes mellitus (DM), which is mainly treated by medication in clinic. Oral hypoglycemic agents can not only optimize blood glucose control and reduce the risk of hypoglycemia, but also affect the progression of DN. Among them, dipeptidyl peptidase-4 inhibitor (DPP-4i) is an oral hypoglycemic agent that plays a role in changes in the level of the incretin system. DPP-4i showed additional pleiotropic effects in vitro models, including reduced inflammation, fibrosis and oxidative damage, further indicating a potential renal protective effect. DPP-4i may help delay DN progression, but further studies are needed to prove their specific benefit to the kidney. This article reviewed the biological function of DPP-4i, the mechanism on DN, and the clinical efficacy, in order to provide new ideas for clinical treatment.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |